Cardarine (GW-501516) is drug that binds for the PPAR receptor. It was initial created by Glaxo Smith Kline and Ligand Pharmaceuticals in 1992. It was discovered that Cardarine, when binding to the PPAR receptor, recruits what is called the coactivator PGC-1a enzyme, which then increases the expression of genes involved in the exs properly as an enhanced protection from type-2 diabetes. In a diffe